Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.17 USD | -5.23% | +20.79% | -4.91% |
14/05 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
14/05 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-4.91% | 324M | |
+8.98% | 114B | |
+11.36% | 104B | |
-12.58% | 22.41B | |
-1.05% | 22.28B | |
-5.29% | 19.07B | |
-38.29% | 18B | |
-2.46% | 17.89B | |
+8.11% | 14.28B | |
+34.93% | 12.55B |
- Stock Market
- Equities
- PSTX Stock
- News Poseida Therapeutics, Inc.
- Poseida Therapeutics to Receive Up to $600 Million in Cancer Gene Therapy Research, Development Deal With Xyphos